Summary of the Medimmune decision, how Lear and Medimmune combine to influence future licensing and royalty decisions, recommendations for what licensees and patent owners should now do, and finally the author describes legislations which he suggested some twenty years ago for addressing this problem (one which patent reformers have ignored).
Excerpts and Summaries
Created
Friday 28 of November, 2008 00:53:03 GMT by Unknown
LastModif
Friday 28 of November, 2008 00:53:03 GMT by Unknown